SMYD3 and Mobius syndrome: To further characterize SMYD3 mRNA expression among the different MB subgroups, we analyzed the Shirsat and Pfister patient datasets, which revealed high expression of SMYD3, particularly in Group 3 MBs (Figure S2A and Figure 2B).